Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MASP2 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | MS4A18 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
mRNA | KIF19 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | STMN3 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
mRNA | SCRT1 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-06 |
mRNA | VN1R1 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
mRNA | MAPK8IP2 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
mRNA | ZNF17 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
mRNA | PER3 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
mRNA | TTF1 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |